Valeant Pharmaceuticals International Inc
(NYSE : VRX)

( )
VRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-10.75%19.6814.1%$423.46m
SAGESAGE Therapeutics, Inc.
-4.02%158.0310.9%$226.59m
SHPGShire PLC Sponsored ADR
-0.08%147.200.4%$159.41m
PRGOPerrigo Co. Plc
-2.27%84.076.6%$82.08m
MNKMallinckrodt Plc
-3.10%23.1218.5%$78.88m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.52%130.827.6%$60.16m
JAZZJazz Pharmaceuticals Plc
-3.65%135.502.2%$53.33m
UTHRUnited Therapeutics Corporation
-0.37%135.7814.5%$51.60m
ICPTIntercept Pharmaceuticals, Inc.
-4.03%61.6122.0%$38.01m
RVNCRevance Therapeutics, Inc.
-5.72%32.1512.2%$36.25m
MDCOMedicines Company
-1.45%27.2522.1%$35.42m
ENDPEndo International Plc
0.00%7.818.9%$32.98m
CTLTCatalent Inc
0.08%40.052.6%$31.80m
ADMSAdamas Pharmaceuticals, Inc.
-3.81%32.0816.9%$31.56m
PTLAPortola Pharmaceuticals, Inc.
-3.73%47.557.8%$30.99m

Company Profile

Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International; The Branded Rx; and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.